Lectin, Galactoside-Binding, Soluble, 8 (LGALS8) Peptide
-
- Target See all LGALS8 products
- LGALS8 (Lectin, Galactoside-Binding, Soluble, 8 (LGALS8))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- FPFSPGMYFE MIIYCDVREF KVAVNGVHSL EYKHRFKELS SIDTLEINGD
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of LGALS8 antibody,
Alternative Names: LGALS8 control peptide, LGALS8 antibody Blocking Peptide, Anti-LGALS8 Blocking Peptide, Lectin Galactoside-Binding Soluble 8 Blocking Peptide, Galectin 8 Blocking Peptide, Gal-8 Blocking Peptide, PCTA-1 Blocking Peptide, PCTA1 Blocking Peptide, Po66-CBP Blocking Peptide, LGALS8, LGALS-8, LGALS 8, LGALS-8 Blocking Peptide, LGALS 8 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- LGALS8 (Lectin, Galactoside-Binding, Soluble, 8 (LGALS8))
- Background
- LGALS8 is a member of the galectin family. Galectins are beta-galactoside-binding animal lectins with conserved carbohydrate recognition domains. The galectins have been implicated in many essential functions including development, differentiation, cell-cell adhesion, cell-matrix interaction, growth regulation, apoptosis, and RNA splicing. This gene is widely expressed in tumoral tissues and seems to be involved in integrin-like cell interactions.
- Molecular Weight
- 39 kDa
-